基因擴增技術市場規模、佔有率和成長分析（按產品、樣本類型、技術、最終用戶和地區）- 產業預測 2025-2032

2023 年全球基因擴增技術市場規模價值 281 億美元，預計將從 2024 年的 301 億美元成長到 2032 年的 521 億美元，預測期內（2025-2032 年）的複合年成長率為 7.1%。

在分子生物學和診斷方法創新的推動下，全球基因擴增技術市場正經歷顯著成長。推動這一趨勢的關鍵因素包括這​​些技術在疾病診斷、個人化醫療和生物技術研究中的應用日益廣泛。市場由聚合酵素鏈鎖反應(PCR) 和等溫擴增技術主導，而基於 CRISPR 的擴增正成為一個引人注目的競爭對手。在廣泛的研發計劃和強大的醫療保健框架的支持下，北美保持著相當大的市場佔有率。同時，由於醫療支出的增加和技術的進步，亞太地區正在經歷快速成長。隨著基因組學領域繼續徹底改變醫學和研究應用，基因擴增技術市場預計將保持成長軌跡。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

基因擴增技術市場規模（依產品分類）

• 市場概況
• 裝置
• 套件和試劑
• 軟體和服務

基因擴增技術市場規模（依樣本類型）

• 市場概況
• 細胞株
• 農業和食品複製品
• 體液
• 組織
• 其他

基因擴增技術市場規模（依技術分類）

• 市場概況
• PCR 擴增
• 恒溫環型核酸擴增
• 基於核酸序列的擴增
• 鏈置換擴增
• 多重置換放大
• 滾環擴增
• 分支擴增
• 其他

基因擴增技術市場規模（依最終用戶分類）

• 市場概況
• 製藥和生物技術公司
• 學術及研究機構
• 醫院和診斷實驗室
• 合約研究組織
• 法醫學實驗室
• 其他

基因擴增技術市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• QIAGEN（Germany）
• New England Biolabs（United States）
• Illumina Inc.（United States）
• Yikang Gene（China）
• Bio-Rad Laboratories（United States）
• Menarini Silicon Biosystems（Italy）
• Merck KGaA（Germany）
• Promega Corporation（United States）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• 4basebio AG（Germany）
• LGC Group（United Kingdom）
• Vazyme Biotech Co. Ltd.（China）
• MyBioSource（United States）
• 10x Genomics（United States）
• Ginkgo Bioworks（United States）
• Thermo Fisher Scientific（United States）
• Agilent Technologies（United States）
• Roche Diagnostics（Switzerland）
• Becton, Dickinson and Company（United States）

結論和建議

Global Gene Amplification Technologies Market size was valued at USD 28.1 billion in 2023 and is poised to grow from USD 30.1 billion in 2024 to USD 52.1 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global gene amplification technologies market is witnessing substantial growth, spurred by innovations in molecular biology and diagnostic methodologies. Major factors driving this trend include the escalating use of these technologies in disease diagnosis, personalized medicine, and biotechnology research. Dominating the market are polymerase chain reaction (PCR) and isothermal amplification techniques, with CRISPR-based amplification emerging as a notable contender. North America maintains a significant market share, bolstered by extensive R&D initiatives and a robust healthcare framework. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increased healthcare spending and technological advancements. As the field of genomics continues to revolutionize medical and research applications, the gene amplification technologies market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segments Analysis

Global Gene Amplification Technologies Market is segmented by Product, Sample Type, Technology, End-user and region. Based on Product, the market is segmented into Instruments, Kits and Reagents and Software & Services. Based on Sample Type, the market is segmented into Cell Lines, Agricultural & Food Samples, Body Fluids, Tissue and Others. Based on Technology, the market is segmented into PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic-Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, Hospitals & Diagnostic Labs, Contract Research Organizations, Forensic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth driven by the rising demand for personalized medicine and the ongoing advancements in biotechnology. These innovative technologies facilitate precise and efficient analysis of genetic material, which is crucial for both diagnostic and research applications. As healthcare increasingly shifts toward tailored treatments and diagnostic methods, the need for accurate gene amplification solutions is surging. This trend underscores the importance of gene amplification technologies in enabling researchers and clinicians to better understand genetic information and develop effective, individualized healthcare strategies, further fueling the expansion of this dynamic market.

Restraints in the Global Gene Amplification Technologies Market

The Global Gene Amplification Technologies market faces several restraints that may impede its growth and broader acceptance. Ethical issues related to genetic manipulation create significant apprehension among stakeholders, while complicated regulatory frameworks add layers of complexity and uncertainty to the development and commercialization processes. Additionally, the high costs associated with implementing gene amplification technologies can deter investment and adoption, further limiting their reach and potential impact. Collectively, these factors contribute to challenges in expanding the market, making it essential for industry players to navigate these obstacles effectively to promote growth and innovation within this vital sector.

Market Trends of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth, driven by advancements in CRISPR-Cas9 technology, which enables precise and efficient gene editing. The increasing applications of these technologies in medical research, agriculture, and biotechnology are further driving expansion. The rise of synthetic biology and personalized medicine is fueling demand for innovative gene amplification tools, while automation and high-throughput capabilities enhance operational efficiency. Despite ethical and regulatory challenges concerning genetic manipulation, the market's trajectory is propelled by continuous innovation, diverse applications, and increased investment in genetic research, focusing on both therapeutic and non-therapeutic applications. This trend underscores the critical role of gene amplification technologies in shaping the future of various industries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Gene Amplification Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits and Reagents
• Software & Services

Global Gene Amplification Technologies Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Cell Lines
• Agricultural & Food Samples
• Body Fluids
• Tissue
• Others

Global Gene Amplification Technologies Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic-Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Rolling Circle Amplification
• Ramification Amplification
• Others

Global Gene Amplification Technologies Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Hospitals & Diagnostic Labs
• Contract Research Organizations
• Forensic Labs
• Others

Global Gene Amplification Technologies Market Size & CAGR (2025-2032)

• North America (Product, Sample Type, Technology, End-user)
  • US
  • Canada
• Europe (Product, Sample Type, Technology, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample Type, Technology, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample Type, Technology, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample Type, Technology, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yikang Gene (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 4basebio AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vazyme Biotech Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations